Cargando…
Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines
BACKGROUND: Similar to human glioblastoma patients, glial tumours in dogs have high treatment resistance and a guarded prognosis. In human medicine, the addition of temozolomide to radiotherapy leads to a favourable outcome in vivo as well as a higher antiproliferative effect on tumour cells in vitr...
Autores principales: | Tresch, Nina Simona, Fuchs, Daniel, Morandi, Luca, Tonon, Caterina, Rohrer Bley, Carla, Nytko, Katarzyna J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604143/ https://www.ncbi.nlm.nih.gov/pubmed/34477324 http://dx.doi.org/10.1002/vms3.620 |
Ejemplares similares
-
Triple combination of lomustine, temozolomide and irradiation reduces canine glioma cell survival in vitro
por: Fuchs, Daniel, et al.
Publicado: (2023) -
Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy
por: Thumser-Henner, Pauline, et al.
Publicado: (2020) -
Methadone does not potentiate the effect of doxorubicin in canine tumour cell lines
por: Cueni, Claudia, et al.
Publicado: (2020) -
Cell line-specific efficacy of thermoradiotherapy in human and canine cancer cells in vitro
por: Nytko, Katarzyna J., et al.
Publicado: (2019) -
Role of HSP70 in response to (thermo)radiotherapy: analysis of gene expression in canine osteosarcoma cells by RNA-seq
por: Nytko, Katarzyna J., et al.
Publicado: (2020)